Varonis Systems (VRNS) Launches Agent IBAC, Is The Stock Still Cheap?

Varonis Systems (VRNS) has introduced Agent Intent-Based Access Control within its Atlas platform, a new AI agent safeguard that checks reasoning and data access, flags risky actions, and can quarantine suspect identities or sessions.

See our latest analysis for Varonis Systems.

Varonis Systems’ latest AI security release lands after a period of strong share price momentum, with a 90 day share price return of 51.13% and a year to date share price return of 40.42%. However, the 1 year total shareholder return declined 23.08%, which indicates that recent enthusiasm has not yet fully reversed earlier weakness.

If Agent IBAC has you rethinking your AI exposure, this is a good moment to look across the market at 56 AI infrastructure stocks

Bulls point to Varonis Systems’ AI product momentum and recent share price strength. Bears focus on ongoing losses and past drawdowns. How does today’s valuation inform perspectives on the next phase for VRNS?

Most Popular Narrative: 1% Undervalued

Varonis Systems most followed valuation narrative puts fair value at $45.55, which sits just above the last close at $44.99, so the gap is tight but meaningful.

Continued SaaS transition and high NRR, notably for SaaS customers, combined with robust upsell momentum across cloud and multi-cloud environments, enhance ARR visibility and predictability, driving durable earnings and margin expansion as the SaaS mix climbs and operational leverage improves post transition.

Read the complete narrative.

Want to see how this ARR story translates into fair value? The narrative leans on compound revenue growth, rising margins and a rich future earnings multiple.

Result: Fair Value of $45.55 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this Varonis Systems narrative can break if SaaS margin pressure persists, or if larger platforms intensify competition and slow ARR and free cash flow progress.

Find out about the key risks to this Varonis Systems narrative.

Another View on Varonis Systems’ Valuation

The analyst narrative puts Varonis Systems close to fair value at around $45. Yet the SWS DCF model tells a different story. It puts fair value at $72.32, with the current $44.99 price sitting well below that. Which version of “fair” do you lean toward as an investor?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

This mix of optimism and concern around Varonis Systems makes it worth checking the underlying data for yourself and moving quickly while sentiment is still split. To weigh both sides in one place, start with the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Varonis Systems?

If Varonis Systems has sharpened your focus on quality, use the Simply Wall St Screener to quickly surface stocks that match clear, evidence based criteria.

• Target steadier potential outcomes by checking companies that appear resilient in tougher conditions with the 80 resilient stocks with low risk scores.
• Hunt for potential mispriced opportunities by reviewing companies that look attractively valued on fundamentals in the 52 high quality undervalued stocks.
• Spot cash rich businesses by filtering for robust balance sheets and solid fundamentals using the solid balance sheet and fundamentals stocks screener (50 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com